Copyright
©The Author(s) 2018.
World J Stem Cells. Mar 26, 2018; 10(3): 23-33
Published online Mar 26, 2018. doi: 10.4252/wjsc.v10.i3.23
Published online Mar 26, 2018. doi: 10.4252/wjsc.v10.i3.23
Growth factors | Profile | Physiological activity | Effect on ASCs | Remarks |
EGF | Small polypeptide of 53 amino acid residues and a molecular mass of approximately 6000 daltons[57] | Development of the oral cavity, lungs, gastrointestinal tract, epidermis, derma, eyelids and central nervous system[56] | Promotion of proliferation with delays of senescence and insurance of differentiation potency[55] | EGF and bFGF co-administration limits ASCs differentiation abilities by inducing ASCs into an ectodermal lineage rather than the mesodermal one[53] |
bFGF | Non-glycosylated polypeptide of 18 kDa and 155 amino acid in length (heparin-binding growth factor family) | Stimulator of tissue repair and cellular viability released from an injured extracellular matrix[64] | Enhancement of proliferation, differentiation and hepatocyte growth factor expression ability[58]. Induction of the adipogenic[59] and chondrogenic[60] potential, with inhibition of osteogenic differentiation[61] | |
PDGF | Dimeric glycoprotein | Potent mitogen for cell of mesodermal lineage and stimulator of tissue repair released from activated platelets on bleeding[65] | Supporting of cell proliferation in vitro: It increases ASCs yield. Promotion of neural differentiation in an antioxidant microenvironment[48] | Receptor-β signalling is involved primarily in ASCs stimulation[62]. ASCs stimulation with autologous platelet-rich plasma reduces the cost of differentiation[48] |
- Citation: Graziano ACE, Avola R, Perciavalle V, Nicoletti F, Cicala G, Coco M, Cardile V. Physiologically based microenvironment for in vitro neural differentiation of adipose-derived stem cells. World J Stem Cells 2018; 10(3): 23-33
- URL: https://www.wjgnet.com/1948-0210/full/v10/i3/23.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v10.i3.23